TipRanks
Immunovant (IMVT)
NASDAQ:IMVT
US Market
IMVT
Immunovant
RESEARCH TOOLSreports
Want to see IMVT full AI Analyst Report?

Immunovant (IMVT) Balance Sheet

964 Followers

Immunovant Balance Sheet

Immunovant's total assets for Q1 2027 were $852.49M, a decrease of -10.92% from the previous quarter. IMVT total liabilities were $117.10M for the fiscal quarter, a 12.14% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Mar 26Mar 25Mar 24Mar 23Mar 22
Total Assets
$ 957.57M$ 776.22M$ 666.71M$ 405.84M$ 515.56M
Total Liabilities
$ 104.97M$ 68.78M$ 48.95M$ 43.34M$ 45.74M
Total Equity Gross Minority
$ 852.59M$ 707.45M$ 617.76M$ 362.49M$ 469.82M
Other Metrics
Currency in USD

Immunovant Debt to Assets